V Flu Technologies, Inc. has signed a letter of intent with a distribution partner for the exclusive rights for retail distribution of UVFT's FDA-cleared ViraTech(TM) UV-400 air purifier that kills more than 99% of airborne bacteria. The distributor has paid a non-refundable $25,000 deposit and the distribution agreement is expected to close by April 21, 2014. Highlights of the proposed distribution agreement include: The distributor will buy UVFT's existing inventory valued at approximately $200,000; UVFT to provide a minimum of 36,000 air purifier units with a retail value of $14 million for the first year; distributor will accept up to 50,000 units if UVFT and UVFT's manufacturer can increase production levels; UVFT to invest approximately $30,000 in the prototyping, testing and production of the RX300 air purifier unit currently in development.